The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-((3aR,6aS)-5-(9-isopropyl-6-(4-(4-methylpiperazin-1-yl)phenylamino)-9H-purin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)prop-2-en-1-one ID: ALA3608430
PubChem CID: 118073591
Max Phase: Preclinical
Molecular Formula: C28H37N9O
Molecular Weight: 515.67
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)N1C[C@@H]2CN(c3nc(Nc4ccc(N5CCN(C)CC5)cc4)c4ncn(C(C)C)c4n3)C[C@@H]2C1
Standard InChI: InChI=1S/C28H37N9O/c1-5-24(38)35-14-20-16-36(17-21(20)15-35)28-31-26(25-27(32-28)37(18-29-25)19(2)3)30-22-6-8-23(9-7-22)34-12-10-33(4)11-13-34/h5-9,18-21H,1,10-17H2,2-4H3,(H,30,31,32)/t20-,21+
Standard InChI Key: CBZIPGPDJXMUAK-OYRHEFFESA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3606 -2.8684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3877 -3.5218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9971 3.0138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2935 3.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 -1.4950 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.7556 -2.9871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9501 -0.8655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2901 5.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5873 6.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8881 5.2761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8917 3.7761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5944 3.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1860 6.0296 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.1849 7.5297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4834 8.2807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.7830 7.5317 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-8.7842 6.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4858 5.2807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.8218 8.1325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9621 -1.9885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2416 -3.2870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2251 -4.4090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.6049 -3.7635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.4195 -2.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.9217 -4.4780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.2015 -3.6942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.9531 -5.6776 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-11.2563 -4.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4588 -1.1206 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.7403 -4.1523 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
5 1 2 0
1 2 1 0
2 3 2 0
3 4 1 0
4 6 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
10 12 1 0
1 13 1 0
13 14 1 0
3 15 1 0
15 16 1 0
16 31 1 0
30 17 1 0
17 15 1 0
14 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 14 1 0
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
20 23 1 0
26 29 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
30 34 1 0
33 35 1 0
35 36 1 0
35 37 2 0
36 38 2 0
30 39 1 6
31 40 1 6
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.67Molecular Weight (Monoisotopic): 515.3121AlogP: 2.98#Rotatable Bonds: 6Polar Surface Area: 85.66Molecular Species: NEUTRALHBA: 9HBD: 1#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 7.97CX LogP: 3.03CX LogD: 2.36Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.50Np Likeness Score: -1.04
References 1. Abdel-Magid AF.. (2015) Inhibitors of the Epidermal Growth Factor Receptor (EGFR) May Provide Effective Treatment for Lung Adenocarcinoma., 6 (7): [PMID:26191356 ] [10.1021/acsmedchemlett.5b00231 ]